Arc Institute’s Post

If you are at PMWC next week come learn about how we are applying AI to genome interpretation to keep pace with the recent increases in sequencing throughput.

One day left to register here (https://lnkd.in/g4BCBKfp) for tomorrow’s webinar “Using Big Data and AI to Improve and Advance Longevity”. Tune in with experts Douglas Anderson, Ulrich Stengele, Gregg TeHennepe, and Steven Baxter for the final session of our Risk of Living Longer Webinar Series, where we will discuss the range of longevity related AI use-cases: preventative medicine, accelerating drug discovery, establishing new genetic connections, and improving operational efficiency in health delivery. We will also explore how the pace of change in longevity will be affected by AI developments, and which age groups are most likely to be affected. 

⚠ Last chance to register for tomorrow's webinar ‘Using Big Data and AI to improve and advance longevity’ We’ll explore the following questions: - What is the range of longevity related AI use-cases? - How will the pace of change in longevity be affected by AI developments? - Which age groups are likely to be most affected? Register here ->https://lnkd.in/g4BCBKfp Club Vita #webinar #longevity #AI #bigdata

Harnessing Genomics and ML for a Healthier Future 🌟🧬🤖 In the rapidly evolving field of healthcare, precision medicine is revolutionizing how we understand, diagnose, and treat diseases by tailoring medical treatments to individual patient characteristics. By combining the power of genomics and machine learning (ML), precision medicine promises highly personalized and effective treatment plans, moving away from traditional one-size-fits-all approaches. Curious about the impact of genomics research? Explore this detailed interactive chart illustrating how Genomics and ML can lead to a healthier future. This visualization showcases the intricate relationship between these technologies and their potential to transform healthcare, providing insights into more accurate diagnoses, personalized treatments, and improved health outcomes for all. Link to the interactive chart 📊🔬 - https://lnkd.in/eQMFbP3k Adapted from a notebook by Mike Bostock. #Genomics #MachineLearning #PrecisionMedicine #Healthcare #PersonalizedMedicine #FutureofHealthcare #Analytics #InteractiveCharts

🌟 Excited to share that my paper titled "Machine Learning Technique for Tuberculosis Detection" has been published in the International Journal of Creative Research Thoughts! 🔬 In this research, we explored cutting-edge machine learning algorithms to enhance the early detection and diagnosis of tuberculosis, aiming to contribute to global health advancements and improve patient outcomes. 📈 Our findings demonstrate the potential of AI-driven techniques to revolutionize healthcare by providing more accurate and timely diagnoses, ultimately saving lives and resources. A heartfelt thank you to my collaborators and mentors for their unwavering support, and to the International Journal of Creative Research Thoughts for this prestigious platform. Looking forward to continuing this journey of innovation and impact in the field of medical technology! #Research #MachineLearning #Healthcare #Tuberculosis #AI #Innovation #MedicalTechnology #IJCRT #AcademicPublishing

Elsevier is revolutionizing the drug discovery game using AI and data science. Repurposing old drugs for new cures is gaining momentum, thanks to innovations like Wegovy. Our Professional Services team, armed with diverse expertise, is at the forefront, solving non-standard puzzles and uncovering hidden gems in the scientific literature. "It’s a passion we all have here in Professional Services... taking this immense amount of data and knowledge, focusing it, and then applying it to cure patients.” says Dr. Anton Yuryev, Consulting Director for Professional Services at Elsevier. From rare diseases to cancer, we're accelerating drug repurposing, applying the same principles to personalized medicine. Collaborations with Wake Forest and nonprofit Every Cure aim to bring precision medicine to the masses. Learn more here: http://spkl.io/604847CXp #Elsevier #DrugRepurposing #AIInnovation #MedicalAdvancements

🚀 Unleashing #AI's potential for rare disease treatment: Dr. David Fajgenbaum, MD, MBA, MSc reveals the innovative work of Every Cure, a pioneering nonprofit harnessing the vast realm of medical knowledge to unveil potential treatments for #RareDisease patients with artificial intelligence.   🎙️ During the UCSF Rare Disease Symposium, our President Dr. James Levine interviewed Dr. Fajgenbaum about leveraging AI algorithms for drug repurposing and evaluating the efficacy of every FDA-approved drug against every rare disease. Watch the full interview 👉 https://lnkd.in/egXRCkSe

HealthNext 2024 is less than one month away and the program is live now on our website. You can now view the complete lineup of speakers, fireside chats, panel discussions, and keynote addresses, covering topics like funding AI applications in clinical care and establishing trust and transparency in the age of AI. Don’t miss out on these important conversations, follow the link on our website to get tickets. #HealthNext24

Imagine a world where the tech in your pocket outpaces the tools in our hospitals. Since the 1950s, we've leaped from black-and-white TVs to AI, yet in medicine, we sometimes cling to methods as outdated as rabbit ear antennas. Why? Advanta Genetics breaks the mold, harnessing PCR technology to detect infectious diseases with unmatched precision and speed. It's time to ask: Why aren't all medical diagnostics advancing as rapidly as our everyday technology? Let's champion the future of healthcare, together. #AdvantaGenetics #ModernMedicine #TechRevolution Image: 🤖📸🔧: AI-made image w/ human-edits

✨In a rapidly evolving medical landscape, it's not enough to be part of the change; we aim to be the catalyst. Alzheimer's detection is on the brink of a transformative era, and we're at the helm. By melding cutting-edge AI with deep medical insights, we're crafting a blueprint for unparalleled precision in detection. But it's not just about technology—it's about a paradigm shift in understanding, approach, and action. We're not just detecting; we're foreseeing, leading the way in a journey from insights to revelations. Join us as we push boundaries, challenge conventions, and usher in a new dawn for Alzheimer's technology. 🌟 To learn more about Optina’s research, click here 👉 https://lnkd.in/eh_xZHbF Alzheimer's Association® Alzheimer's Disease International #IlluminateWithOptina #BeyondTheKnown #TrailblazingTech #VisionaryTech #OptinaPioneers #CraftingTheFuture